Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors

Basic and Clinical Pharmacology and Toxicology

Volumn 117, Issue 4, 2015, Pages 261-266

  Betts, Stina ^a   Björkhem Bergman, Linda ^a   Rane, Anders ^a   Ekström, Lena ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 3A4; CYTOCHROME P450 3A7; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PREGNANE X RECEPTOR; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CELL RECEPTOR; CYP3A4 PROTEIN, HUMAN; CYP3A7 PROTEIN, HUMAN; CYTOCHROME P450 3A; STEROID RECEPTOR; UNSPECIFIC MONOOXYGENASE; VDR PROTEIN, HUMAN;

ADRENAL GLAND; ADULT; ARTICLE; CONTROLLED STUDY; FETUS; FETUS (ANATOMY); FETUS LIVER; GENE EXPRESSION; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INTESTINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION; AGED; EMBRYOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GESTATIONAL AGE; LIVER; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION;

ADRENAL GLANDS; ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE FREQUENCY; GESTATIONAL AGE; HUMANS; INTESTINES; LIVER; MIDDLE AGED; POLYMORPHISM, GENETIC; PPAR ALPHA; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID;

EID: 84940900843     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12392     Document Type: Article

References (31)

1. Daly AK. Significance of the minor cytochrome P450 3A isoforms. Clin Pharmacokinet 2006;45:13-31.
2. Hines RN. Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 2007;21:169-75.
3. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T. Expression of CYP3A in the human liver-evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 1997;247:625-34.
4. Wilkening S, Bader A. Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. Basic Clin Pharmacol Toxicol 2004;95:92-3.
5. Canaparo R, Nordmark A, Finnstrom N, Lundgren S, Seidegard J, Jeppsson B et al. Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples. Basic Clin Pharmacol Toxicol 2007;100:240-8.
6. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 1999;37:485-505.
7. Olesen C, Steffensen FH, Nielsen GL, de Jong-van den Berg L, Olsen J, Sørensen HT. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur J Clin Pharmacol 1999;55:139-44.
8. Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003;188:1039-45.
9. Garland M, Abildskov KM, Kiu TW, Daniel SS, Stark RI. The contribution of fetal metabolism to the disposition of morphine. Drug Metab Dispos 2005;33:68-76.
10. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Bäckman M et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 1998;95:12208-13.
11. Lamba J, Lamba V, Strom S, Venkataramanan R, Schuetz E. Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression. Drug Metab Dispos 2008;36:169-81.
12. Thirumaran RK, Lamba JK, Kim RB, Urquhart BL, Gregor JC, Chande N et al. Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation. Biochem Pharmacol 2012;84:104-12.
13. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 2002;277:25125-32.
14. Lindh JD, Andersson ML, Eliasson E, Björkhem-Bergman L. Seasonal variation in blood drug concentrations and a potential relationship to vitamin D. Drug Metab Dispos 2011;39:933-7.
15. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011;377:242-50.
16. Selvaraj P, Chandra G, Jawahar MS, Rani MV, Rajeshwari DN, Narayanan PR. Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol 2004;24:523-32.
17. de Keyser CE, Becker ML, Uitterlinden AG, Hofman A, Lous JJ, Elens L et al. Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study. Pharmacogenomics 2013;14:1295-304.
18. Klein K, Thomas M, Winter S, Nussler AK, Niemi M, Schwab M et al. PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo. Clin Pharmacol Ther 2012;91:1044-52.
19. Thomas M, Burk O, Klumpp B, Kandel BA, Damm G, Weiss TS et al. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα). Mol Pharmacol 2013;83:709-18.
20. Ekstrom L, Johansson M, Rane A. Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus. Drug Metab Dispos 2013;41:291-5.
21. von Bahr C, Groth CG, Jansson H, Lundgren G, Lind M, Glaumann H. Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther 1980;27:711-25.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.
23. Leeder JS, Gaedigk R, Marcucci KA, Gaedigk A, Vyhlidal CA, Schindel BP et al. Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther 2005;314:626-35.
24. Wolbold R, Klein K, Burk O, Nüssler AK, Neuhaus P, Eichelbaum M et al. Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 2003;38:978-88.
25. Wang H, Ping J, Peng RX, Yue J, Xia XY, Li QX et al. Changes of multiple biotransformation phase I and phase II enzyme activities in human fetal adrenals during fetal development. Acta Pharmacol Sin 2008;29:231-8.
26. Rane A, Henningsson S, Ask B, Ladona MG. Comparison of human fetal hepatic and adrenal cytochrome P450 activities with some major gestational steroids and ethylmorphine as substrates. J Steroid Biochem Mol Biol 1992;43:335-41.
27. Nishimura M, Naito S, Yokoi T. Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug Metab Pharmacokinet 2004;19:135-49.
28. Nylén H, Björkhem-Bergman L, Ekström L, Roh HK, Bertilsson L, Eliasson E et al. Plasma Levels of 25-Hydroxyvitamin D3 and In Vivo Markers of Cytochrome P450 3A Activity in Swedes and Koreans: Effects of a Genetic Polymorphism and Oral Contraceptives. Basic Clin Pharmacol Toxicol 2014;115(4):366-71.
29. Al-Daghri NM, Guerini FR, Al-Attas OS, Alokail MS, Alkharfy KM, Draz HM et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLoS One 2014;9:e102141.
30. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-7.
31. Vyhlidal CA, Gaedigk R, Leeder JS. Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression. Drug Metab Dispos 2006;34:131-7.